BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp.verified

BCT.TO

Price:

$15.8

Market Cap:

$21.50M

BriaCell Therapeutics Corp., an immuno-oncology-focused biotechnology company, engages in developing immunotherapies for the management of cancer. Its lead drug candidate is Bria-IMT, a whole-cell cancer vaccine that is in Phase I/IIa clinical trials in combination with the immunotherapy development candidates retifanlimab. The company is also developing Bria-OTS, an off-the-shelf personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test that determines the patients' HLA types. It has a non-exclusive clinical trial collaboration with Incyte Corporation to evaluate the effects of combinations of novel clinical candidates; and a cooperative research and development a...[Read more]

Industry

Biotechnology

IPO Date

2012-08-13

Stock Exchange

TSX

Ticker

BCT.TO

The PE Ratio as of December 2025 (TTM) for BriaCell Therapeutics Corp. (BCT.TO) is -0.18

According to BriaCell Therapeutics Corp.’s latest financial reports and current stock price. The company's current PE Ratio is -0.18. This represents a change of -98.54% compared to the average of -12.33 of the last 4 quarters.

BriaCell Therapeutics Corp. (BCT.TO) Historical PE Ratio (quarterly & annually)

How has BCT.TO PE Ratio performed in the past?

The mean historical PE Ratio of BriaCell Therapeutics Corp. over the last ten years is -6912.35. The current -0.18 PE Ratio has changed -99.74% with respect to the historical average. Over the past ten years (40 quarters), BCT.TO's PE Ratio was at its highest in in the July 2020 quarter at 83.24. The PE Ratio was at its lowest in in the January 2021 quarter at -31847.29.

Quarterly (TTM)
Annual

Average

-6912.35

Median

-83.91

Minimum

-32009.94

Maximum

49.22

BriaCell Therapeutics Corp. (BCT.TO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of BriaCell Therapeutics Corp. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 50.63%

Maximum Annual PE Ratio = 49.22

Minimum Annual Increase = -263.22%

Minimum Annual PE Ratio = -32009.94

Quarterly (TTM)
Annual
YearPE RatioChange
2024-18554.5236.22%
2023-51.08-41.61%
2022-87.488.89%
2021-80.34-263.22%
202049.22-100.27%
2019-18145.16-43.31%
2018-32009.9450.63%
2017-63.10-46.25%
2016-117.3984.32%
2015-63.691.88%

BriaCell Therapeutics Corp. (BCT.TO) Average PE Ratio

How has BCT.TO PE Ratio performed in the past?

The current PE Ratio of BriaCell Therapeutics Corp. (BCT.TO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-6231.03

5-year avg

-3744.84

10-year avg

-6912.35

BriaCell Therapeutics Corp. (BCT.TO) PE Ratio vs. Peers

How is BCT.TO’s PE Ratio compared to its peers?

BriaCell Therapeutics Corp.’s PE Ratio is greater than Resverlogix Corp. (-5.85), greater than Perimeter Medical Imaging AI, Inc. (-0.77), greater than Rapid Dose Therapeutics Corp. (-4.18), greater than Gemina Laboratories Ltd. (-4.19), greater than Pangenomic Health Inc. (-4.92), greater than Telescope Innovations Corp. (-25.33), greater than Greenway Greenhouse Cannabis Corporation (-13.34), greater than Hemostemix Inc. (-2.25), greater than Izotropic Corporation (-6.22), greater than Microbix Biosystems Inc. (-103.87),

Build a custom stock screener for BriaCell Therapeutics Corp. (BCT.TO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BriaCell Therapeutics Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BriaCell Therapeutics Corp. (BCT.TO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BriaCell Therapeutics Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is BriaCell Therapeutics Corp.'s PE Ratio?

How is the PE Ratio calculated for BriaCell Therapeutics Corp. (BCT.TO)?

What is the highest PE Ratio for BriaCell Therapeutics Corp. (BCT.TO)?

What is the 3-year average PE Ratio for BriaCell Therapeutics Corp. (BCT.TO)?

What is the 5-year average PE Ratio for BriaCell Therapeutics Corp. (BCT.TO)?

How does the current PE Ratio for BriaCell Therapeutics Corp. (BCT.TO) compare to its historical average?